Therapix Biosciences Ltd (TRPX) Stock Price, Forecast & Analysis
USA - NASDAQ:TRPX -
TRPX Key Statistics, Chart & Performance
The current stock price of TRPX is 0.317 null. In the past month the price decreased by -39.04%. In the past year, price decreased by -87.11%.
TRPX Latest News, Press Relases and Analysis
About TRPX
Company Profile
Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.
Company Info
Therapix Biosciences Ltd
4 ARIEL SHARON STREET HASHAHAR TOWER 16TH FLOOR
GIVATAYIM L3 5320047
CEO: Gilad Bar-Lev
Phone: 972-3616-7055
Therapix Biosciences Ltd / TRPX FAQ
What does TRPX do?
Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.
What is the current price of TRPX stock?
The current stock price of TRPX is 0.317 null. The price decreased by -48.9% in the last trading session.
What is the dividend status of Therapix Biosciences Ltd?
TRPX does not pay a dividend.
What is the ChartMill rating of Therapix Biosciences Ltd stock?
TRPX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists TRPX stock?
TRPX stock is listed on the Nasdaq exchange.
TRPX Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TRPX. When comparing the yearly performance of all stocks, TRPX is a bad performer in the overall market: 96.97% of all stocks are doing better.
TRPX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TRPX. Both the profitability and financial health of TRPX have multiple concerns.
TRPX Financial Highlights
Over the last trailing twelve months TRPX reported a non-GAAP Earnings per Share(EPS) of -1.04. The EPS increased by 57.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -230.26% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |